These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 11337025)

  • 1. The psychobiology of anxiolytic drugs. Part 1: Basic neurobiology.
    Sandford JJ; Argyropoulos SV; Nutt DJ
    Pharmacol Ther; 2000 Dec; 88(3):197-212. PubMed ID: 11337025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurobiologic basis of anxiety and its treatment.
    Salzman C; Miyawaki EK; le Bars P; Kerrihard TN
    Harv Rev Psychiatry; 1993; 1(4):197-206. PubMed ID: 9384849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The psychobiology of anxiolytic drug. Part 2: Pharmacological treatments of anxiety.
    Argyropoulos SV; Sandford JJ; Nutt DJ
    Pharmacol Ther; 2000 Dec; 88(3):213-27. PubMed ID: 11337026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacology of anxiety.
    Durant C; Christmas D; Nutt D
    Curr Top Behav Neurosci; 2010; 2():303-30. PubMed ID: 21309115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mechanism of action, indications and abuse of benzodiazepine anxiolytic drugs].
    Goffinet S
    Ann Med Psychol (Paris); 1993 Jan; 151(1):47-63. PubMed ID: 7905724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressant-anxiolytic interactions: involvement of the benzodiazepine-GABA and serotonin systems.
    Suranyi-Cadotte BE; Bodnoff SR; Welner SA
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(5):633-54. PubMed ID: 1705717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The GABAA-BZR complex as target for the development of anxiolytic drugs.
    Trincavelli ML; Da Pozzo E; Daniele S; Martini C
    Curr Top Med Chem; 2012; 12(4):254-69. PubMed ID: 22204488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GABAergic hypotheses of anxiety and depression: focus on GABA-B receptors.
    Pilc A; Nowak G
    Drugs Today (Barc); 2005 Nov; 41(11):755-66. PubMed ID: 16395415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Research in anxiety disorders: from the bench to the bedside.
    Garner M; Möhler H; Stein DJ; Mueggler T; Baldwin DS
    Eur Neuropsychopharmacol; 2009 Jun; 19(6):381-90. PubMed ID: 19327970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The neurochemistry of anxiety: an update.
    Nutt DJ; Glue P; Lawson C
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(5):737-52. PubMed ID: 1963497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anxiety and the mechanisms of action of anxiolytics].
    Marino A; Costa R
    Recenti Prog Med; 1993 Feb; 84(2):129-41. PubMed ID: 8096650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New anxiolytics in development.
    Mosconi M; Chiamulera C; Recchia G
    Int J Clin Pharmacol Res; 1993; 13(6):331-44. PubMed ID: 7916335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anxiety.
    Braestrup C; Nielsen M
    Lancet; 1982 Nov; 2(8306):1030-4. PubMed ID: 6127510
    [No Abstract]   [Full Text] [Related]  

  • 14. GABAA receptors as targets for novel anxiolytic drugs.
    Rupprecht R; Eser D; Zwanzger P; Möller HJ
    World J Biol Psychiatry; 2006; 7(4):231-7. PubMed ID: 17071543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of 5-HT₁A receptors in the medial subdivision of the central nucleus of the amygdala produces anxiolytic effects in a rat model of Parkinson's disease.
    Sun YN; Wang T; Wang Y; Han LN; Li LB; Zhang YM; Liu J
    Neuropharmacology; 2015 Aug; 95():181-91. PubMed ID: 25797491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generalized anxiety disorder: neurobiological and pharmacotherapeutic perspectives.
    Connor KM; Davidson JR
    Biol Psychiatry; 1998 Dec; 44(12):1286-94. PubMed ID: 9861471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testing efficacy of natural anxiolytic compounds.
    Roberts AA
    Adv Exp Med Biol; 2004; 546():181-91. PubMed ID: 15584374
    [No Abstract]   [Full Text] [Related]  

  • 18. Neurotransmitters in anxiety.
    Hoehn-Saric R
    Arch Gen Psychiatry; 1982 Jun; 39(6):735-42. PubMed ID: 6124225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The age of anxiety: role of animal models of anxiolytic action in drug discovery.
    Cryan JF; Sweeney FF
    Br J Pharmacol; 2011 Oct; 164(4):1129-61. PubMed ID: 21545412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quetiapine anxiolytic-like effect in the Vogel conflict test is serotonin dependent.
    Pisu C; Pira L; Pani L
    Behav Pharmacol; 2010 Oct; 21(7):649-53. PubMed ID: 20802307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.